VTYX News

The fall IPO market kept a brisk pace this past week with 11 IPOs, led by restaurant chain Portillo’s (PTLO). SPACs also stayed active, with 18 blank check IPOs. There was one postponement: winery Winc (WBEV). New filers continue to flood the pipeline, with 14 IPOs and X SPACs submitting initial filings. Portillo’s (PTLO) priced...read more

Ventyx Biosciences, a Phase 1 biotech developing selective therapies for inflammatory and autoimmune diseases, raised $152 million by offering 9.5 million shares at $16, within the range of $15 to $17. The company offered 1.7 million more shares than anticipated. Ventyx is focused on advancing new therapies for patients living with inflammatory diseases and autoimmune disorders....read more

Updated Monday, 10/18. 11 IPOs are slated to raise $2.0 billion led by restaurant chain Portillo’s (PTLO). The diverse group also features investment management software, water pipelines, coconut water, and crypto mining. Portillo’s (PTLO), known for its Chicago-style hot dogs, plans to raise $375 million at a $1.3 billion...read more

Ventyx Biosciences, a Phase 1 biotech developing selective therapies for inflammatory and autoimmune diseases, announced terms for its IPO on Friday. The Encinitas, CA-based company plans to raise $125 million by offering 7.8 million shares at a price range of $15 to $17. At the midpoint of the proposed range, Ventyx Biosciences would command a fully diluted market value of $815...read more